Intimation of change of management under regulation 30 of SEBI LODR 2015

Kimia Biosciences' Board meeting on April 4, 2026 resulted in multiple governance changes. Two new Additional Non-Executive Independent Directors were appointed: Mr. Avinash Prabhat and Ms. Reema Goyal, both company secretaries with over 5 years of experience in corporate and SEBI laws. All four Board committees (Audit, NRC, SRC, and CSR) were reconstituted to include the new directors alongside MD & CEO Sameer Goel. Mr. Jagdeep Dhawan stepped down as Independent Director on March 28, 2026 after completing a 10-year tenure. More notably, Ms. Pallavi Garg resigned as Company Secretary & Compliance Officer effective April 3, 2026 citing personal reasons. The company immediately appointed Mr. Abhishek Kumar Pandey, a qualified Company Secretary with over 10 years of experience in SEBI, LODR, and Corporate Laws, to replace her effective April 4, 2026. Mr. Pandey has also been designated as the authorized KMP for determining materiality of events under Regulation 30(5).